Trial Profile
Open Label Phase 1 Pharmacokinetics and Tolerability Study of Single TAB08 Administration in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Feb 2017
Price :
$35
*
At a glance
- Drugs Theralizumab (Primary)
- Indications Chronic lymphocytic leukaemia; Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors TheraMAB
- 10 Sep 2013 New trial record